Brief: Cocrystal Pharma Q2 Net Income USD -5.026 Million
14/08/2023 13:00
Aug 14 (Reuters) - Cocrystal Pharma Q2 basic EPS USD -0.5. * Q2 operating expenses USD 5.199 million * Q2 operating income USD -5.199 million
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway